Childhood Neurotechnology and Developmental Cognitive Sovereignty in the Global Cognitive Economy
Neuroethics · 2026-08 · 19 (2)
DOI: 10.1007/s12152-026-09666-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuroethics, online erschienen am 05.08.2026. Verfasst von George Chingarande. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Stellenbosch University.
Abstract (Originalsprache)
The rapid expansion of consumer neurotechnology presents a defining ethical challenge of technological modernity: how to protect developing minds from becoming sites of commercial extraction while preserving developmental openness for future generations. Advances in neurostimulation devices, wearable electroencephalographic (EEG) systems, neurofeedback applications, adaptive educational technologies, and brain-computer interface research have increasingly shifted from specialised clinical environments into consumer, educational, and behavioural optimisation markets [ 1 , 2 , 3 ]. While many of these technologies hold legitimate therapeutic promise, their growing diffusion into childhood formative spaces raises complex ethical questions concerning vulnerability, identity formation, cognitive autonomy, and the preservation of healthy developmental trajectories.
Förderung
- Stellenbosch University
Zitieren
APA
Chingarande, G. (2026). Childhood Neurotechnology and Developmental Cognitive Sovereignty in the Global Cognitive Economy. Neuroethics, 19(2). https://doi.org/10.1007/s12152-026-09666-0
Vancouver
Chingarande G. Childhood Neurotechnology and Developmental Cognitive Sovereignty in the Global Cognitive Economy. Neuroethics. 2026;19(2). doi:10.1007/s12152-026-09666-0
BibTeX
@article{Chingarande2026,
author = {Chingarande, George},
title = {Childhood Neurotechnology and Developmental Cognitive Sovereignty in the Global Cognitive Economy},
journal = {Neuroethics},
year = {2026},
volume = {19},
number = {2},
doi = {10.1007/s12152-026-09666-0}
}
EUVIMED